The difficulty in selling the Ineligible Shareholder Shares
15 Under the scheme, the AMAL shares that would otherwise have been issued to the Ineligible Shareholders (Ineligible Shareholder Shares) were to be issued to a sale agent. The sale agent was then to sell the Ineligible Shareholder Shares on financial markets within a certain timeframe and pay the aggregate net proceeds to the Ineligible Shareholders on a pro rata basis.
16 AMAL appointed Canaccord Genuity (Australia) Ltd (Canaccord) as the sale agent.
17 The sale process to be undertaken by Canaccord was also set out in the scheme. Relevantly, cl 6.8(b) provides that:
AMAL would procure that, as soon as reasonably practicable and in any event not more than 15 Business Days after the Implementation Date, the sale agent sells all of the AMAL shares issued to the sale agent … in such manner on such financial market at such price and on such other terms as the sale agent determines in good faith and at the risk of the Ineligible Shareholders.
18 'Business Day' was defined in the scheme to mean a business day as defined in the ASX Listing Rules. The ASX Listing Rules define 'Business Day' as 'Monday to Friday inclusive except New Year's Day, Good Friday, Easter Monday, Christmas Day, Boxing Day and any other day that the ASX declares is not a business day'.
19 The Implementation Date as defined by the scheme was Friday 14 December 2018, meaning that the time period within which Canaccord was to sell the shares expired on 9 January 2019, being 15 Business Days after 14 December 2018.
20 Canaccord was unable to sell the Ineligible Shareholder Shares on the ASX by 9 January 2019. The evidence relied upon by Tawana explained that the reasons were as follows:
(a) Canaccord did not attempt to start selling the shares in the first two ASX trading days after 14 December 2018, because it wished to observe 'normalised trading volumes' and institutional demand after implementation of the scheme;
(b) there was a low daily trading volume of AMAL shares between Monday 17 December 2018 and Thursday 20 December 2018;
(c) the securities of AMAL were placed in a trading halt between Friday 21 December 2018 and Wednesday 26 December 2018;
(d) the securities of AMAL were suspended from quotation from Thursday 27 December 2018 until Tuesday 15 January 2019; and
(e) Canaccord refused to sell the shares from Wednesday 16 January 2019 without a court order.
21 AMAL commenced trading on the ASX on 5 December 2018. The trading halt and suspension in trading were a direct result of an ASX market announcement about pending changes to AMAL's lithium offtake arrangements. The suspension of trading was lifted once AMAL made an announcement about those changes on 15 January 2019.
22 According to Mr Alexei Fedotov, the general manager and legal and company secretary of Tawana, when the scheme was being negotiated and prepared, the parties did not contemplate that the AMAL shares would not trade in an ordinary fashion or would be subject to any trading halt or suspension. Based on disclosure from other similar transactions, Tawana considered that 15 business days was a reasonable period for Canaccord to sell the relevant shares. However, Mr Fedotov deposed to there being extenuating circumstances that arose due to a dispute between AMAL and one of its counterparties to a lithium offtake agreement, and in order to comply with its continuous disclosure obligations, AMAL requested the trading halt and then suspension, pending appropriate information being provided to the market. Mr Fedotov also deposed to the fact that during the trading halt and suspension period, Tawana and AMAL received inquiries from Ineligible Shareholders asking when the Ineligible Shareholder Shares would be sold.
23 There is no doubt that taking into account the trading halt and suspension from quotation of the AMAL shares, the time period during which Canaccord was able to facilitate sales of the Ineligible Shareholder Shares was severely truncated. As a matter of fact, the time period was reduced from the anticipated 15 days to some seven days. Further, one can well understand Canaccord's reluctance to sell the remaining Ineligible Shareholder Shares outside the specific period provided for by the scheme, absent disclosure to the Court.
24 The intervention of the trading halt and suspension is, in my view, the principal reason why Canaccord found itself in a position where it was unable to sell the shares within the window provided by the scheme.
25 I accept that the trading halt and suspension was unanticipated.
26 I do not accept that the other difficulties referred to (the desire to observe trading patterns, potential low volume sales) were matters that could or would not have been considered at the time. The terms of the scheme had been carefully considered both for the purpose of the circulation of the first scheme booklet and then again at the time of supplementary disclosure by the supplementary scheme booklet. The period of 15 business days had been actively considered by Tawana, as Mr Fedotov's evidence disclosed. Further, as Mr Fedotov stated, the period of 15 business days for a sale of shares by a selling agent was not unusual in such schemes.
27 Counsel referred to other examples of selling periods, said to have been ascertained by reference to relevant ASX announcements available on the ASX website and the Morningstar DatAnalysis databases. Counsel noted that in each of Re Wesfarmers Ltd; ex parte Wesfarmers Ltd [No 2] [2018] WASC 357 (Vaughan J), Excelsior Gold Limited, in the matter of Excelsior Gold Limited [2018] FCA 2064 (McKerracher J), and Aphrodite Gold Limited, in the matter of Aphrodite Gold Limited (No 2) [2017] FCA 1625 (Siopis J) the prescribed time period was 15 business days. In Re Westfield Corporation Ltd (No 2) [2018] NSWSC 921 (Black J) and Fairfax Media Limited, in the matter of Fairfax Media Limited (No 2) [2017] FCA 1313 (Yates J) the prescribed time period was 20 business days. In Altona Mining Limited, in the matter of Altona Mining Limited [2018] FCA 614 (McKerracher J) and Cobalt One Limited, in the matter of Cobalt One Limited (No 2) [2017] FCA 1407 (Siopis J) the prescribed time period was 30 business days. In Fairfax Media Limited, in the matter of Fairfax Media Limited (No 2) [2018] FCA 1930 (Gleeson J) the prescribed time period was 30 days. In SRG Limited, in the matter of SRG Limited (No 2) [2018] FCA 1424 the prescribed time period was as soon as reasonably practicable (with no fixed maximum time period). The schemes the subject of Re Wesfarmers and Fairfax Media Limited (Yates J) provided for a longer period of time if determined necessary by the company proposing the scheme and the sale agent, subject to obtaining any necessary Australian Securities and Investment Commission (ASIC) exemptions or waivers.
28 These examples confirm that there is nothing unusual of itself in a 15 business day selling period.